These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 30261177)

  • 41. [Primary enuresis -- combination therapy with oxybutynin plus desmopressin shows good results].
    Brudermanns B
    Aktuelle Urol; 2007 Mar; 38(2):86-8. PubMed ID: 17390271
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of Low Dose Imipramine in Patients with Nocturnal Enuresis, A Randomized Clinical Trial.
    Ravanshad Y; Azarfar A; Esmaeeli M; Mostafavian Z; Zahabi E; Ravanshad S
    Iran J Kidney Dis; 2019 Jul; 13(4):257-261. PubMed ID: 31422392
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the efficacy of desmopressin fast-melting formulation and enuretic alarm in the treatment of monosymptomatic nocturnal enuresis.
    Keten T; Aslan Y; Balci M; Erkan A; Senel C; Oguz U; Kayali M; Guzel O; Karabulut E; Tuncel A
    J Pediatr Urol; 2020 Oct; 16(5):645.e1-645.e7. PubMed ID: 32826183
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 'Frequently recurring' nocturnal polyuria is predictive of response to desmopressin in monosymptomatic nocturnal enuresis in childhood.
    Marzuillo P; Marotta R; Guarino S; Fedele MC; Palladino F; Capalbo D; Della Vecchia N; Miraglia Del Giudice E; Polito C; La Manna A
    J Pediatr Urol; 2019 Apr; 15(2):166.e1-166.e7. PubMed ID: 30528650
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does structured withdrawal of desmopressin improve relapse rates in patients with monosymptomatic enuresis?
    Gökçe Mİ; Hajıyev P; Süer E; Kibar Y; Sılay MS; Gürocak S; Doğan HS; Irkılata HC; Oktar T; Önal B; Erdem E; Aygün YC; Balcı C; Arslan AR; Kaya C; Soygür T; Sarıkaya S; Tekgül S; Burgu B
    J Urol; 2014 Aug; 192(2):530-4. PubMed ID: 24518770
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does desmopressin withdrawal strategy affect relapse rates in monosymptomatic enuresis treatment?
    Issi Y; Biçakci U
    Eur J Pediatr; 2021 May; 180(5):1453-1457. PubMed ID: 33389072
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis.
    Robson WL; Leung AK; Norgaard JP
    J Urol; 2007 Jul; 178(1):24-30. PubMed ID: 17574054
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The efficacy of alarm therapy versus desmopressin therapy in the treatment of primary mono-symptomatic nocturnal enuresis: a systematic review.
    Perrin N; Sayer L; While A
    Prim Health Care Res Dev; 2015 Jan; 16(1):21-31. PubMed ID: 24252606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combination therapy (desmopressin plus oxybutynin) improves the response rate compared with desmopressin alone in patients with monosymptomatic nocturnal enuresis and nocturnal polyuria and absence of constipation predict the response to this treatment.
    Capalbo D; Guarino S; Di Sessa A; Esposito C; Grella C; Papparella A; Miraglia Del Giudice E; Marzuillo P
    Eur J Pediatr; 2023 Apr; 182(4):1587-1592. PubMed ID: 36693995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pretreatment morning urine osmolality and oral desmopressin lyophilisate treatment outcome in patients with primary monosymptomatic enuresis.
    Abdovic S; Cuk M; Hizar I; Milosevic M; Jerkovic A; Saraga M
    Int Urol Nephrol; 2021 Aug; 53(8):1529-1534. PubMed ID: 33774753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Did the removal of the indication of nocturnal enuresis for intranasal desmopressin change prescribing practice?
    Hoffmann F; Glaeske G; Steuber C
    Pharmacoepidemiol Drug Saf; 2011 Jan; 20(1):105-9. PubMed ID: 21182158
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The efficacy of the addition of short-term desmopressin to alarm therapy in the treatment of primary nocturnal enuresis.
    Ozden C; Ozdal OL; Aktas BK; Ozelci A; Altinova S; Memis A
    Int Urol Nephrol; 2008; 40(3):583-6. PubMed ID: 18320340
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prospective evaluation of factors affecting the response and relapse rates to desmopressin therapy in male monosymptomatic enuretic adults.
    Burgu B; Gökce MI; Gücük A; Soygür T
    Urology; 2009 Oct; 74(4):915-9. PubMed ID: 19643460
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Poor compliance with primary nocturnal enuresis therapy may contribute to insufficient desmopressin response.
    Van Herzeele C; Alova I; Evans J; Eggert P; Lottmann H; Nørgaard JP; Vande Walle J
    J Urol; 2009 Oct; 182(4 Suppl):2045-9. PubMed ID: 19695639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination of the enuresis alarm and desmopressin: second line treatment for nocturnal enuresis.
    Kamperis K; Hagstroem S; Rittig S; Djurhuus JC
    J Urol; 2008 Mar; 179(3):1128-31. PubMed ID: 18206924
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A prospective and randomized study comparing the use of alarms, desmopressin and imipramine in the treatment of monosymptomatic nocturnal enuresis.
    Mello MF; Locali RF; Araujo RM; Reis JN; Saiovici S; Mello LF; Trigo Rocha FE
    J Pediatr Urol; 2023 Jun; 19(3):241-246. PubMed ID: 36717289
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is second-line enuretic alarm therapy after unsuccessful pharmacotherapy superior to first-line therapy in the treatment of monosymptomatic nocturnal enuresis?
    Tuygun C; Eroglu M; Bakirtas H; Gucuk A; Zengin K; Imamoglu A
    Urol Int; 2007; 78(3):260-3. PubMed ID: 17406138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tailoring treatment of monosymptomatic nocturnal enuresis: the role of maximum voided capacity.
    Tauris LH; Kamperis K; Hagstroem S; Bower WF; Rittig S
    J Urol; 2012 Feb; 187(2):664-9. PubMed ID: 22177206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of effects of treatment of primary nocturnal enuresis with oxybutynin plus desmopressin, desmopressin alone or imipramine alone: a randomized controlled clinical trial.
    Lee T; Suh HJ; Lee HJ; Lee JE
    J Urol; 2005 Sep; 174(3):1084-7. PubMed ID: 16094064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Study of the profile of behavioral problems and quality of life indexes in a pediatric cohort of monosymptomatic enuresis.
    Sousa E Silva GJ; Sammour SNF; Ferraro AA; Koch VHK
    J Pediatr (Rio J); 2019; 95(2):188-193. PubMed ID: 29428322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.